FIELD: chemistry.
SUBSTANCE: invention relates to novel quinoline derivatives of general formula II, where R1 denotes halogen, R2 denotes halogen, R3 denotes hydroxy, R4, R5 denote C1-C3-alkyl, R6 denotes aryl, R7 denotes aryl, n=1 or 2, as well as to pharmaceutically acceptable acid or base addition salts thereof, having activity towards mycobacteria. The invention also relates to a method for synthesis of formula II compounds.
EFFECT: obtaining novel quinoline derivatives with useful biological activity.
3 cl, 4 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
QUINOLINE DERIVATIVES, PARTICULARLY 6,7-SUBSTITUTED 1-(2-CHLOROQUINOLIN-3-YL)-4-DIMETHYLAMINO-2-(NAPHTHALEN-1-YL)-1-PHENYLBUTAN-2-OLS, METHOD FOR PRODUCTION THEREOF AND USE OF COMPOUNDS TO TREAT INFECTIOUS MYCOBACTERIAL DIESEASES, PARTICULARLY TUBERCULOSIS | 2013 |
|
RU2530493C1 |
QUINOLINE DERIVATIVES, PARTICULARLY 5,6,7-SUBSTITUTED 1-(2-CHLOROQUINOLIN-3-YL)-4-DIMETHYLAMINO-2-(NAPHTHALEN-1-YL)-1-PHENYLBUTAN-2-OLES, METHOD FOR PREPARING AND USING COMPOUNDS | 2011 |
|
RU2486175C2 |
β-CARBOLINE DERIVATIVES, POSSESSING ANTI-TUBERCULOSIS ACTIVITY, THEIR APPLICATION FOR MEDICATION MANUFACTURING, METHOD OF THEIR SYNTHESIS, AS WELL AS NOVEL METHODS OF TREATMENT WITH THEIR APPLICATION | 2010 |
|
RU2419431C1 |
METHOD FOR DIAGNOSIS OF SENSITIVITY OF MYCOBACTERIUM TUBERCULOSIS TO ANTITUBERCULOSIS PREPARATIONS | 2005 |
|
RU2315113C2 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2471787C1 |
DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
PHENYL FORMAMIDINE DERIVATIVES, HAVING ANTIMYCOBACTERIAL ACTIVITY | 2018 |
|
RU2702224C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
Authors
Dates
2010-11-27—Published
2008-12-02—Filed